Literature DB >> 9620773

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

P Timpl1, R Spanagel, I Sillaber, A Kresse, J M Reul, G K Stalla, V Blanquet, T Steckler, F Holsboer, W Wurst.   

Abstract

Corticotropin-releasing hormone (CRH) is a potent mediator of endocrine, autonomic, behavioural and immune responses to stress, and has been implicated in the stress-like and other aversive consequences of drug abuse, such as withdrawal from alcohol. Two CRH receptors, Crhr1 and Crhr2, have been identified in the mouse. Crhr1 is highly expressed in the anterior pituitary, neocortex, hippocampus, amygdala and cerebellum, and activation of this receptor stimulates adenylate cyclase. Here we show that in mice lacking Crhr1, the medulla of the adrenal gland is atrophied and stress-induced release of adrenocorticotropic hormone (ACTH) and corticosterone is reduced. The homozygous mutants exhibit increased exploratory activity and reduced anxiety-related behaviour under both basal conditions and following alcohol withdrawal. Our results demonstrate a key role of the Crhr1 receptor in mediating the stress response and anxiety-related behaviour.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620773     DOI: 10.1038/520

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  213 in total

Review 1.  The neurobiology of stress and gastrointestinal disease.

Authors:  E A Mayer
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

Review 2.  Lessons learned from gene targeting and transgenesis for adrenal physiology and disease.

Authors:  A Böttner; S R Bornstein
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

3.  White matter microstructure varies with post-traumatic stress severity following medical trauma.

Authors:  Nathaniel G Harnett; Edward W Ference; Amy J Knight; David C Knight
Journal:  Brain Imaging Behav       Date:  2020-08       Impact factor: 3.978

4.  Central infusion of ovine CRF (oCRF) potentiates defensive behaviors in CD-1 mice in the Mouse Defense Test Battery (MDTB).

Authors:  Mu Yang; Catherine Farrokhi; Amy Vasconcellos; Robert J Blanchard; D Caroline Blanchard
Journal:  Behav Brain Res       Date:  2006-04-18       Impact factor: 3.332

Review 5.  Pharmacogenetic studies of alcohol self-administration and withdrawal.

Authors:  John C Crabbe; Tamara J Phillips
Journal:  Psychopharmacology (Berl)       Date:  2003-10-09       Impact factor: 4.530

6.  Forebrain-specific CRF overproduction during development is sufficient to induce enduring anxiety and startle abnormalities in adult mice.

Authors:  Mate Toth; Jodi E Gresack; Debra A Bangasser; Zach Plona; Rita J Valentino; Elizabeth I Flandreau; Isabelle M Mansuy; Emilio Merlo-Pich; Mark A Geyer; Victoria B Risbrough
Journal:  Neuropsychopharmacology       Date:  2013-12-11       Impact factor: 7.853

7.  Sex differences in corticotropin-releasing factor receptor-1 action within the dorsal raphe nucleus in stress responsivity.

Authors:  Alexis R Howerton; Alison V Roland; Jessica M Fluharty; Anikò Marshall; Alon Chen; Derek Daniels; Sheryl G Beck; Tracy L Bale
Journal:  Biol Psychiatry       Date:  2013-10-23       Impact factor: 13.382

8.  Fractal dynamics of heart beat interval fluctuations in corticotropin-releasing factor receptor subtype 2 deficient mice.

Authors:  Oliver Stiedl; Michael Meyer
Journal:  Integr Physiol Behav Sci       Date:  2002 Oct-Dec

9.  A sexually dimorphic distribution of corticotropin-releasing factor receptor 1 in the paraventricular hypothalamus.

Authors:  Zachary J Rosinger; Jason S Jacobskind; Rose M De Guzman; Nicholas J Justice; Damian G Zuloaga
Journal:  Neuroscience       Date:  2019-05-02       Impact factor: 3.590

Review 10.  Pituitary Adenylate Cyclase-Activating Peptide (PACAP) Signaling and the Dark Side of Addiction.

Authors:  Olivia W Miles; Victor May; Sayamwong E Hammack
Journal:  J Mol Neurosci       Date:  2018-08-03       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.